170 related articles for article (PubMed ID: 15538930)
1. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice.
Schlumberger M; Pacini F; Wiersinga WM; Toft A; Smit JW; Sanchez Franco F; Lind P; Limbert E; Jarzab B; Jamar F; Duntas L; Cohen O; Berg G
Eur J Endocrinol; 2004 Nov; 151(5):539-48. PubMed ID: 15538930
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategy of papillary microcarcinoma of the thyroid gland: a nuclear medicine perspective.
Riemann B; Schober O
Minerva Endocrinol; 2009 Mar; 34(1):81-7. PubMed ID: 19209130
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.
Carhill AA; Litofsky DR; Ross DS; Jonklaas J; Cooper DS; Brierley JD; Ladenson PW; Ain KB; Fein HG; Haugen BR; Magner J; Skarulis MC; Steward DL; Xing M; Maxon HR; Sherman SI
J Clin Endocrinol Metab; 2015 Sep; 100(9):3270-9. PubMed ID: 26171797
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic strategy in thyroid carcinoma].
Baschieri L; Antonelli A; Del Guerra P
Clin Ter; 1987 Jun; 121(6):457-65. PubMed ID: 2973881
[No Abstract] [Full Text] [Related]
6. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
7. A Follow-Up Strategy for Patients with an Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma: Less Is Better.
Jeon MJ; Kim M; Park S; Oh HS; Kim TY; Kim WB; Shong YK; Kim WG
Thyroid; 2018 Feb; 28(2):187-192. PubMed ID: 29179642
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of differentiated thyroid carcinomas. Prospective study].
Gemsenjäger E; Staub JJ; Heitz PU
Schweiz Med Wochenschr; 1985 Feb; 115(5):153-9. PubMed ID: 3975583
[TBL] [Abstract][Full Text] [Related]
9. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.
Lamartina L; Durante C; Lucisano G; Grani G; Bellantone R; Lombardi CP; Pontecorvi A; Arvat E; Felicetti F; Zatelli MC; Rossi R; Puxeddu E; Morelli S; Torlontano M; Crocetti U; Montesano T; Giubbini R; Orlandi F; Aimaretti G; Monzani F; Attard M; Francese C; Antonelli A; Limone P; Rossetto R; Fugazzola L; Meringolo D; Bruno R; Tumino S; Ceresini G; Centanni M; Monti S; Salvatore D; Spiazzi G; Mian C; Persani L; Barbaro D; Nicolucci A; Filetti S
Thyroid; 2017 Dec; 27(12):1490-1497. PubMed ID: 29020892
[TBL] [Abstract][Full Text] [Related]
10. [Thyroid carcinoma in children (author's transl)].
Joppich I; Röher HD; Hecker WC; Knorr D; Daum R
Klin Padiatr; 1980 Sep; 192(5):436-9. PubMed ID: 7192339
[TBL] [Abstract][Full Text] [Related]
11. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
12. Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.
Hundeshagen H
Eur J Nucl Med; 1983; 8(12):541-5. PubMed ID: 6667704
[No Abstract] [Full Text] [Related]
13. The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma.
Pelikan DM; Lion HL; Hermans J; Goslings BM
Clin Endocrinol (Oxf); 1997 Dec; 47(6):713-20. PubMed ID: 9497879
[TBL] [Abstract][Full Text] [Related]
14. Cost of Care.
Levy EG
Thyroid; 2000 Dec; 10(12):1119-21. PubMed ID: 11201859
[No Abstract] [Full Text] [Related]
15. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
Zakavi SR; Kakhki VD
Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
[No Abstract] [Full Text] [Related]
16. Papillary carcinoma simultaneously involving thyroid, neck lymph-nodes, ovary and bone marrow.
Giovanella L; Suriano S; Ceriani L; Verburg FA
Nuklearmedizin; 2010; 49(6):N66-8. PubMed ID: 21140033
[No Abstract] [Full Text] [Related]
17. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
18. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.
Simon D; Goretzki PE; Witte J; Röher HD
World J Surg; 1996 Sep; 20(7):860-6; discussion 866. PubMed ID: 8678963
[TBL] [Abstract][Full Text] [Related]
19. Survival of differentiated thyroid carcinoma studied in 500 patients.
Lerch H; Schober O; Kuwert T; Saur HB
J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine therapy for differentiated thyroid carcinoma.
Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
